Quantifying the Harms and Benefits from Serosorting Among HIV-Negative Gay and Bisexual Men: A Systematic Review and Meta-analysis
We conducted a systematic review and meta-analysis of the association between serosorting and HIV infection among HIV-negative men who have sex with men (MSM). Compared to no condomless anal sex (i.e., consistent condom use or no anal sex), serosorting was associated with increased HIV risk (RR = 1.64, 95% CI 1.37–1.96). Compared to condomless discordant anal sex, serosorting was associated with reduced HIV risk (RR = 0.46, 95% CI 0.33–0.65). Serosorting may be an important harm reduction strategy when condoms are not consistently used, but can be harmful if HIV-negative MSM who consistently use condoms shift to using serosorting as their primary prevention strategy. The protective effects of serosorting and ways in which MSM are operationalizing serosorting are becoming more complex as additional factors affecting risk are considered (e.g., durable viral load suppression, PrEP). Understanding the potential risk and benefit of serosorting continues to be important, particularly within the context of other prevention strategies.
KeywordsHIV MSM Serosorting Meta-analysis Systematic review
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
Research Involving Human Participants
This article does not contain any studies with human participants performed by any of the authors.
- 1.Centers for Disease Control and Prevention. HIV Surveillance Report. 2015; 27. http://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2015-vol-27.pdf. Accessed 14 May 2017.
- 12.Centers for Disease Control and Prevention. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV – United States, 2016. http://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf. Accessed 14 May 2017.
- 13.Kennedy CE, Bernard LJ, Muessig KE, et al. Serosorting and HIV/STI infection among HIV-negative MSM and transgender people: a systematic review and meta-analysis to inform WHO guidelines. J Sex Transm Dis. 2013; Article ID 583627, 8 pages. doi: 10.1155/2013/583627.
- 14.Centers for Disease Control and Prevention. HIV risk reduction (RR) efficacy review methods. http://www.cdc.gov/hiv/pdf/research/interventionresearch/compendium/rr/cdc-hiv-rr_review_methods.pdf. Accessed 14 May 2017.
- 22.Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks: Sage Publications; 2001.Google Scholar
- 23.Cooper H, Hedges LV. The handbook of research synthesis. New York: Russell Sage Foundation; 1994.Google Scholar
- 29.Bavinton BR, Jin F, Prestage GP, et al. Viral load awareness and risk behaviour in male serodiscordant couples in Australia, Brazil and Thailand. 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Vancouver, Canada, July 19–22, 2015 [Abstract TUAC0306].Google Scholar
- 30.Khosropour CM, Katz DA, Dombrowski JC, Golden MR. Nuanced seroadaptive behaviors among Seattle men who have sex with men (MSM): sexual decision-making based on ART use/viral load and recency of partner HIV testing. 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Vancouver, Canada, July 19–22, 2015 [Abstract TUAC0305].Google Scholar
- 32.Kippax S. Negotiated safety agreements among gay men. In: O’Leary A, editor. Beyond condoms: alternative approaches to HIV prevention. New York: Kluwer/Plenum Publishers; 2002. p. 1–15.Google Scholar
- 34.Centers for Disease Control and Prevention. HIV risk and prevention estimates. http://www.cdc.gov/hiv/risk/estimates/index.html. Accessed 14 May 2017.
- 35.Centers for Disease Control and Prevention. Start talking. Stop HIV. http://www.cdc.gov/actagainstaids/campaigns/starttalking/index.html. Accessed 14 May 2017.
- 36.Centers for Disease Control and Prevention. HIV risk reduction tool. https://www.cdc.gov/hivrisk. Accessed 14 May 2017.